Canaccord Genuity Downgrades Beauty Health to Hold, Lowers Price Target to $2.5
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Susan Anderson downgraded Beauty Health (NASDAQ:SKIN) from Buy to Hold and reduced the price target from $10 to $2.5.
November 14, 2023 | 11:12 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Canaccord Genuity downgraded Beauty Health from Buy to Hold and significantly lowered the price target from $10 to $2.5.
The downgrade from Buy to Hold by a reputable analyst firm like Canaccord Genuity, coupled with a substantial reduction in the price target, is likely to negatively impact investor sentiment and the stock price of Beauty Health in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100